Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hormonal Regulation01:40

Hormonal Regulation

Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mesenchymal-derived neural progenitors underlie local <i>insulin</i> production and neuronal transdifferentiation during retina regeneration.

bioRxiv : the preprint server for biology·2026
Same author

Sexually Dimorphic Response to Dietary Restriction-induced Longevity and Muscle Rejuvenation in <i>Nothobranchius furzeri</i>.

bioRxiv : the preprint server for biology·2026
Same author

Zebrafish genetic model of neuromuscular degeneration associated with Atrogin-1 expression.

PLoS genetics·2026
Same author

Zebrafish genetic model of neuromuscular degeneration associated with Atrogin-1 expression.

bioRxiv : the preprint server for biology·2025
Same author

The small molecule ML233 is a direct inhibitor of tyrosinase function.

Communications biology·2025
Same author

The small molecule ML233 is a direct inhibitor of tyrosinase function.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jun 30, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

Hormonal dimorphism in sarcopenia disease.

Romain Menard1, Romain Madelaine1

  • 1MDI Biological Laboratory, Kathryn W. Davis Center for Regenerative Biology and Aging, Bar Harbor, Maine 04609, USA.

Aging
|June 29, 2026
PubMed
Summary

Sarcopenia, or age-related muscle loss, differs significantly between sexes due to hormonal variations. Understanding these sex-specific pathways is crucial for developing effective, personalized treatments for sarcopenia.

Keywords:
hormonal dimorphismmuscle agingsarcopeniasex-stratified medicinesexual dimorphism

More Related Videos

Skeletal Muscle Gender Dimorphism from Proteomics
09:29

Skeletal Muscle Gender Dimorphism from Proteomics

Published on: December 14, 2011

Related Experiment Videos

Last Updated: Jun 30, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

Skeletal Muscle Gender Dimorphism from Proteomics
09:29

Skeletal Muscle Gender Dimorphism from Proteomics

Published on: December 14, 2011

Area of Science:

  • Gerontology
  • Endocrinology
  • Muscle Physiology

Background:

  • Sarcopenia affects over 60% of individuals over 80, posing a global health challenge.
  • Current sarcopenia treatments lack pharmacological options and assume universal pathophysiology.
  • Clinical outcomes show significant variability, suggesting underlying sex-specific differences in muscle aging.

Purpose of the Study:

  • To investigate sexual dimorphism in sarcopenia pathophysiology.
  • To analyze the roles of apelin, insulin, and oxytocin in sex-specific muscle aging.
  • To propose sex-stratified therapeutic strategies for sarcopenia.

Main Methods:

  • Review of pathophysiological mechanisms of sarcopenia.
  • Focus on the hormonal regulatory network of apelin, insulin, and oxytocin.
  • Analysis of effects on satellite-cell dysfunction, proteostasis, stress, and inflammation.

Main Results:

  • Sarcopenia pathways differ fundamentally between men and women.
  • Women: Menopausal estrogen decline impacts apelin signaling, insulin resistance, and oxytocin function.
  • Men: Gradual deterioration linked to testosterone reduction; apelin is a biomarker in women, myostatin in men.

Conclusions:

  • Current sarcopenia therapies may be suboptimal due to sex-specific mechanisms.
  • Lack of sex-disaggregated research creates critical knowledge gaps.
  • Effective sarcopenia management requires understanding peptide-hormone deregulation and developing sex-stratified treatments.